{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T15:24:54Z","timestamp":1773156294628,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1124\/mol.112.081935","type":"journal-article","created":{"date-parts":[[2013,2,8]],"date-time":"2013-02-08T02:47:02Z","timestamp":1360291622000},"page":"930-938","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Vesnarinone Suppresses TNF\u03b1 mRNA Expression by Inhibiting Valosin-Containing Protein"],"prefix":"10.1016","volume":"83","author":[{"given":"Kentaro","family":"Hotta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Nashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiji","family":"Yasumura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoki","family":"Azuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Iizumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Shima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryusuke","family":"Nabeshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Hiramoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kumiko","family":"Sakata-Sogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makio","family":"Tokunaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takumi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Ando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuaki","family":"Kabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Aizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Imai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Handa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/mol.112.081935_bib1","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.cell.2008.06.048","article-title":"UBXD7 binds multiple ubiquitin ligases and implicates p97 in HIF1alpha turnover","volume":"134","author":"Alexandru","year":"2008","journal-title":"Cell"},{"key":"10.1124\/mol.112.081935_bib2","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1349-7006.2002.tb02172.x","article-title":"VCP (p97) regulates NFkappaB signaling pathway, which is important for metastasis of osteosarcoma cell line","volume":"93","author":"Asai","year":"2002","journal-title":"Jpn J Cancer Res"},{"key":"10.1124\/mol.112.081935_bib3","doi-asserted-by":"crossref","first-page":"25757","DOI":"10.1074\/jbc.M513699200","article-title":"Crucial mitochondrial impairment upon CDC48 mutation in apoptotic yeast","volume":"281","author":"Braun","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.112.081935_bib4","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/1071-9164(95)90030-6","article-title":"Vesnarinone: a new inotropic agent for treating congestive heart failure","volume":"1","author":"Cavusoglu","year":"1995","journal-title":"J Card Fail"},{"key":"10.1124\/mol.112.081935_bib5","doi-asserted-by":"crossref","first-page":"34944","DOI":"10.1074\/jbc.M109.037952","article-title":"COP9 signalosome interacts ATP-dependently with p97\/valosin-containing protein (VCP) and controls the ubiquitination status of proteins bound to p97\/VCP","volume":"284","author":"Cayli","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.112.081935_bib6","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1158\/1541-7786.MCR-09-0239","article-title":"Gallic acid suppresses lipopolysaccharide-induced nuclear factor-kappaB signaling by preventing RelA acetylation in A549 lung cancer cells","volume":"7","author":"Choi","year":"2009","journal-title":"Mol Cancer Res"},{"key":"10.1124\/mol.112.081935_bib7","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1056\/NEJM199812173392503","article-title":"A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure","volume":"339","author":"Cohn","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1124\/mol.112.081935_bib8","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1074\/jbc.273.6.3562","article-title":"Involvement of valosin-containing protein, an ATPase Co-purified with IkappaBalpha and 26 S proteasome, in ubiquitin-proteasome-mediated degradation of IkappaBalpha","volume":"273","author":"Dai","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.112.081935_bib9","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/35087056","article-title":"Valosin-containing protein is a multi-ubiquitin chain-targeting factor required in ubiquitin-proteasome degradation","volume":"3","author":"Dai","year":"2001","journal-title":"Nat Cell Biol"},{"key":"10.1124\/mol.112.081935_bib10","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1128\/MCB.16.4.1295","article-title":"Mapping of the inducible IkappaB phosphorylation sites that signal its ubiquitination and degradation","volume":"16","author":"DiDonato","year":"1996","journal-title":"Mol Cell Biol"},{"key":"10.1124\/mol.112.081935_bib11","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1093\/nar\/11.5.1475","article-title":"Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei","volume":"11","author":"Dignam","year":"1983","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/mol.112.081935_bib12","first-page":"1180","article-title":"Vesnarinone exhibits antitumor effect against myeloid leukemia cells via apoptosis","volume":"25","author":"Fujiwara","year":"1997","journal-title":"Exp Hematol"},{"key":"10.1124\/mol.112.081935_bib13","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1002\/hep.510270514","article-title":"Inhibition of NFkappaB in activated rat hepatic stellate cells by proteasome inhibitors and an IkappaB super-repressor","volume":"27","author":"Hellerbrand","year":"1998","journal-title":"Hepatology"},{"key":"10.1124\/mol.112.081935_bib14","first-page":"867","article-title":"Identification of differentiation-inducing activity produced by human bone marrow stromal cell line LP101","volume":"14","author":"Hiramoto","year":"2004","journal-title":"Int J Mol Med"},{"key":"10.1124\/mol.112.081935_bib15","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/sj.bjc.6690327","article-title":"Vesnarinone and glucocorticoids cooperatively induce G1 arrest and have an anti-tumour effect on human non-small cell lung carcinoma cells grown in nude mice","volume":"80","author":"Honma","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1124\/mol.112.081935_bib16","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1126\/science.1177319","article-title":"Identification of a primary target of thalidomide teratogenicity","volume":"327","author":"Ito","year":"2010","journal-title":"Science"},{"key":"10.1124\/mol.112.081935_bib17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0014-2999(93)90545-S","article-title":"Ca2+(-)dependent and Ca2+(-)independent vasorelaxation induced by cardiotonic phosphodiesterase inhibitors","volume":"240","author":"Itoh","year":"1993","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/mol.112.081935_bib18","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1083\/jcb.200908115","article-title":"Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease","volume":"187","author":"Ju","year":"2009","journal-title":"J Cell Biol"},{"key":"10.1124\/mol.112.081935_bib19","first-page":"41","article-title":"Antitumor effect of vesnarinone on human hepatocellular carcinoma cell lines","volume":"14","author":"Kubo","year":"1999","journal-title":"Int J Oncol"},{"key":"10.1124\/mol.112.081935_bib20","doi-asserted-by":"crossref","first-page":"5815","DOI":"10.4049\/jimmunol.164.11.5815","article-title":"Vesnarinone suppresses TNF-induced activation of NF-kappa B, c-Jun kinase, and apoptosis","volume":"164","author":"Manna","year":"2000","journal-title":"J Immunol"},{"key":"10.1124\/mol.112.081935_bib21","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1172\/JCI117438","article-title":"Treatment of virus-induced myocardial injury with a novel immunomodulating agent, vesnarinone. Suppression of natural killer cell activity and tumor necrosis factor-alpha production","volume":"94","author":"Matsui","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1124\/mol.112.081935_bib22","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1038\/ncb2367","article-title":"The ubiquitin-selective segregase VCP\/p97 orchestrates the response to DNA double-strand breaks","volume":"13","author":"Meerang","year":"2011","journal-title":"Nat Cell Biol"},{"key":"10.1124\/mol.112.081935_bib23","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/ncb2407","article-title":"Emerging functions of the VCP\/p97 AAA-ATPase in the ubiquitin system","volume":"14","author":"Meyer","year":"2012","journal-title":"Nat Cell Biol"},{"key":"10.1124\/mol.112.081935_bib24","first-page":"509","article-title":"Effects of vesnarinone on the bone marrow stromal cell-dependent proliferation and differentiation of HL60 cells in vitro","volume":"25","author":"Nabeshima","year":"1997","journal-title":"Exp Hematol"},{"key":"10.1124\/mol.112.081935_bib25","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/00001813-199708000-00007","article-title":"A quinolinone derivative, vesnarinone (OPC-8212), significantly inhibits the in vitro and in vivo growth of human pancreatic cancer cell lines","volume":"8","author":"Nio","year":"1997","journal-title":"Anticancer Drugs"},{"key":"10.1124\/mol.112.081935_bib26","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.colsurfb.2008.01.013","article-title":"Development of novel magnetic nano-carriers for high-performance affinity purification","volume":"64","author":"Nishio","year":"2008","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1124\/mol.112.081935_bib27","doi-asserted-by":"crossref","first-page":"7931","DOI":"10.1038\/sj.onc.1206527","article-title":"Artificial oncoproteins: modified versions of the yeast bZip protein GCN4 induce cellular transformation","volume":"22","author":"Nishizawa","year":"2003","journal-title":"Oncogene"},{"key":"10.1124\/mol.112.081935_bib28","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1124\/mol.65.6.1344","article-title":"Herbimycin A abrogates nuclear factor-kappaB activation by interacting preferentially with the IkappaB kinase beta subunit","volume":"65","author":"Ogino","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.112.081935_bib29","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/ncb2301","article-title":"Endolysosomal sorting of ubiquitylated caveolin-1 is regulated by VCP and UBXD1 and impaired by VCP disease mutations","volume":"13","author":"Ritz","year":"2011","journal-title":"Nat Cell Biol"},{"key":"10.1124\/mol.112.081935_bib30","doi-asserted-by":"crossref","first-page":"7844","DOI":"10.1074\/jbc.271.13.7844","article-title":"Role of IkappaBalpha ubiquitination in signal-induced activation of NFkappaB in vivo","volume":"271","author":"Roff","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.112.081935_bib31","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1016\/S0022-2828(95)91695-4","article-title":"Inotropic agent vesnarinone inhibits cytokine production and E-selectin expression in human umbilical vein endothelial cells","volume":"27","author":"Sato","year":"1995","journal-title":"J Mol Cell Cardiol"},{"key":"10.1124\/mol.112.081935_bib32","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/78496","article-title":"High-performance affinity beads for identifying drug receptors","volume":"18","author":"Shimizu","year":"2000","journal-title":"Nat Biotechnol"},{"key":"10.1124\/mol.112.081935_bib33","first-page":"1419","article-title":"Novel proteasome inhibitor PS-341 inhibits activation of nuclear factor-kappa B, cell survival, tumor growth, and angiogenesis in squamous cell carcinoma","volume":"7","author":"Sunwoo","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1124\/mol.112.081935_bib34","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1097\/00005344-198906000-00002","article-title":"New positive inotropic agent OPC-8212 modulates single Ca2+ channels in ventricular myocytes of guinea pig","volume":"13","author":"Yatani","year":"1989","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1124\/mol.112.081935_bib35","doi-asserted-by":"crossref","first-page":"6372","DOI":"10.4049\/jimmunol.165.11.6372","article-title":"Involvement of the ubiquitin-proteasome pathway in the degradation of nontyrosine kinase-type cytokine receptors of IL-9, IL-2, and erythropoietin","volume":"165","author":"Yen","year":"2000","journal-title":"J Immunol"},{"key":"10.1124\/mol.112.081935_bib36","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0304-3835(99)00061-0","article-title":"Effect of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (vesnarinone) on the growth of gastric cancer cell lines","volume":"140","author":"Yokozaki","year":"1999","journal-title":"Cancer Lett"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24036976?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24036976?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.112.081935","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T11:05:34Z","timestamp":1739963134000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24036976"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0026895X24036976"],"URL":"https:\/\/doi.org\/10.1124\/mol.112.081935","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vesnarinone Suppresses TNF\u03b1 mRNA Expression by Inhibiting Valosin-Containing Protein","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.112.081935","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2013 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}